| Company profile | We are a leading biotechnology company based in Germany. Our focus is on providing top-quality serological tests for tropical and emerging infectious diseases.
Leveraging our patented technology platform, our serological tests have superior specificity and sensitivity, especially targeting the priority diseases in the WHO blueprint list, such as COVID-19, Crimean-Congo hemorrhagic fever, Ebola virus disease, Marburg virus disease, Lassa fever, Rift Valley fever, Zika, and more. The exceptional performance characteristics of our tests have proven that we provide the best tools for scientists, researchers, and health authorities to conduct outbreak monitoring, infection surveillance, and seroprevalence studies.
We offer sorely-needed diagnostics to enable communities in the fight against known global threats and Disease X.
|
| Products & Services | We offer the following ELISA kits to detect IgG or IgM in human samples:
Panadea CCHFV IgG ELISA Kit
Panadea CCHFV IgM ELISA Kit
Panadea ZIKV IgG ELISA Kit
Panadea ZIKV IgM ELISA Kit
Panadea LASV IgG ELISA Kit
Panadea LASV IgM ELISA Kit
Panadea SARS-CoV-2 IgG ELISA Kit
Panadea SARS-CoV-2 IgM ELISA Kit
Panadea SARS-CoV-2 IgG ELISA Kit Plus
Panadea EBOV IgG ELISA Kit
Panadea SUDV IgG ELISA Kit
Panadea MARV IgG ELISA Kit
Panadea Pan-DENV IgG ELISA Kit
Panadea Pan-DENV IgM ELISA Kit
|
| References and export activities | Some of our users:
– Bernhard-Nocht-Institute for Tropical Medicine, Germany
– Pandemic Science Institute, Oxford, UK
– Hokkaido University, Japan
– University of Florida, USA
– CDC, USA
– Erasmus, Netherlands
…
|
| Target group | – Institutes and Universities
– National health labs
– WHO
– Biotech companies
– Diagnostic labs
– Hospitals
|
| Competitive advantages | – Our patented technology platform enables us to develop serological tests with superior specificity and sensitivity compared with current existing products on the global market.
– We focus on tropical infectious diseases.
|
| Ideal Business Partners | – Distributors
– Biotechnology company that offers serological tests but lacks of the portfolio of tropical diseases
|
